Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Nuvelo's Secreted Protein Find Leads To Agreement With Kirin

April 5, 2005

By Jennifer Boggs

Nuvelo's Secreted Protein Find Leads To Agreement With Kirin

April 5, 2005

By Jennifer Boggs

Progenics Raising $30M For MNTX, HIV, Cancer Programs

April 4, 2005

By Jennifer Boggs

BioCurex licenses biomarker to Abbott in 1st major deal

April 4, 2005

By Jennifer Boggs

Progenics Raising $30M For MNTX, HIV, Cancer Programs

April 4, 2005

By Jennifer Boggs

ESBATech's Platform Subject Of Oncology Deal With Novartis

April 1, 2005

By Jennifer Boggs

ESBATech's Platform Subject Of Oncology Deal With Novartis

April 1, 2005

By Jennifer Boggs

Agennix Raises $22M Privately To Advance Lactoferrin Program

March 31, 2005

By Jennifer Boggs

Agennix Raises $22M Privately To Advance Lactoferrin Program

March 31, 2005

By Jennifer Boggs

BioCurex Licenses Biomarker To Abbott In First Significant Deal

March 30, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...